login
Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 




Featured Highlights
1 - 20 of 154   Items
Learn the language of oncology

Learn the language of oncology

Thursday, 28 May 2015
The World Conference on Interventional Oncology (WCIO) is developing an online interventional oncology curriculum called IO University. Michael Soulen, immediate past chair of the WCIO, told Interventional News: “One of the gaps in interventional radiology training is in oncology education. The IO University is designed to address these gaps.” Learn the language of oncology
CeloNova gets US FDA approval for clinical trial with Oncozene

CeloNova gets US FDA approval for clinical trial with Oncozene

Friday, 14 Nov 2014
CeloNova BioSciences has announced that the US FDA has granted approval to start an investigational device exemption (IDE) clinical trial for its Oncozene embolic microspheres, loaded with doxorubicin, a chemotherapy drug used in the treatment of hepatocellular carcinoma. CeloNova gets US FDA approval for clinical trial with Oncozene

Terumo Europe to create an Interventional Oncology division

Tuesday, 04 Nov 2014
Terumo Europe has announced the creation of an Interventional Oncology division that will be active as of 1 April 2015. The specialisation of the interventional oncology team will allow Terumo Europe to be more focused, and thus more efficient in this fast growing market, a press release from the company states. Terumo Europe to create an Interventional Oncology division
SIR-Spheres recommended in new oncology clinical guidelines for treatment of metastatic colorectal cancer

SIR-Spheres recommended in new oncology clinical guidelines for treatment of metastatic colorectal cancer

Tuesday, 30 Sep 2014
Newly published European Society for Medical Oncology (ESMO) clinical guidelines for the treatment of metastatic colorectal cancer endorse radioembolisation, specifically with yttrium-90 (Y90) resin microspheres, as a clinically proven technology to “prolong time to liver tumour progression” in patients who have failed to respond to available chemotherapy options. SIR-Spheres recommended in new oncology clinical guidelines for treatment of metastatic colorectal cancer
Sirtex expands business into Brazil

Sirtex expands business into Brazil

Tuesday, 09 Sep 2014
Sirtex has announced the expansion of its business in Latin America. Sirtex’s SIR-Spheres microspheres are now available to treat inoperable liver tumours in Brazil. Sirtex expands business into Brazil

First patient enrolled in global phase III OPTIMA study of ThermoDox in primary liver cancer

Friday, 05 Sep 2014
Celsion Corporation has announced that the first patient has been enrolled in its pivotal phase III OPTIMA study of ThermoDox in combination with optimised radiofrequency ablation in patients with hepatocellular carcinoma. The first patient was treated at Kyungpook National University Hospital in South Korea. First patient enrolled in global phase III OPTIMA study of ThermoDox in primary liver cancer
DC Bead approved by China Food and Drug Administration

DC Bead approved by China Food and Drug Administration

Tuesday, 02 Sep 2014
BTG and its partner SciClone Pharmaceuticals have announced that the China Food and Drug Administration has approved the registration of DC Bead for the embolization of malignant hypervascularised tumours. DC Bead approved by China Food and Drug Administration

Study identifies tumour-promoting role of EGFR present in liver macrophages

Monday, 01 Sep 2014
A study group at the Comprehensive Cancer Centre of Medical University of Vienna and AKH Vienna under the guidance of Maria Sibilia from the Institute for Cancer Research has discovered that tumorigenisis of epidermal growth factor receptor (EGFR) does not, as previously assumed, depend on its presence within the tumour cell, but rather from its activity in the cells adjacent to the tumour. Study identifies tumour-promoting role of EGFR present in liver macrophages
The microenvironment of solid tumours matters

The microenvironment of solid tumours matters

Friday, 08 Aug 2014
Despite the rapid growth of imaging and treatment options in interventional oncology, one area that has been poorly understood and overlooked by the interventional community is the role of the tumour microenvironment and its impact on the delivery of therapeutic agents, writes Aravind Arepally. The microenvironment of solid tumours matters

Vascular Solutions launches Gel-Bead bioresorbable embolization spheres

Friday, 01 Aug 2014
Vascular Solutions has announced the US market launch of its Gel-Bead embolization spheres for the treatment of hypervascular tumours. Vascular Solutions launches Gel-Bead bioresorbable embolization spheres
Trial shows significant pain relief for spine cancer patients following targeted radiofrequency ablation treatment

Trial shows significant pain relief for spine cancer patients following targeted radiofrequency ablation treatment

Wednesday, 23 Jul 2014
The study followed patients at five leading academic centres and found a significant decrease (p <0.01) in pain scores after targeted radiofrequency ablation (t-RFA) with the Star (DFINE) tumour ablation system. Trial shows significant pain relief for spine cancer patients following targeted radiofrequency ablation treatment
Liver tumour ablation more predictable with Emprint

Liver tumour ablation more predictable with Emprint

Thursday, 17 Jul 2014
Covidien has unveiled an advanced ablation system that offers physicians predictable results regardless of the target location or tissue type. Liver tumour ablation more predictable with Emprint
Pressure-directed embolotherapy using antireflux devices to perform liver directed regional therapy

Pressure-directed embolotherapy using antireflux devices to perform liver directed regional therapy

Tuesday, 08 Jul 2014
Unintended non-target delivery of embolic agents into any of the various hepaticoentric arteries that course from an intrahepatic artery to implant into an extra hepatic organ such as the stomach or small intestine can result in serious complications, especially gastrointestinal ulcerations, particularly with Y-90 microspheres. Now, temporary antireflux devices are available that appear to provide both adequate retrograde and antegrade protection against nontarget delivery of cytotoxic agents, Pressure-directed embolotherapy using antireflux devices to perform liver directed regional therapy

Terumo obtains regulatory approvals for marketing MicroThermX in additional countries

Friday, 27 Jun 2014
BSD Medical Corporation reported that Terumo Europe NV (Terumo) has obtained approvals to market and import the MicroThermX Microwave Ablation System in South Africa, Dubai, Qatar, and Jordan. Terumo obtains regulatory approvals for marketing MicroThermX in additional countries
Three millimetre “ice ball” margin beyond renal tumours adequate for effective cryoablation

Three millimetre “ice ball” margin beyond renal tumours adequate for effective cryoablation

Friday, 13 Jun 2014
The results from a small, animal study challenge previously unsubstantiated published reports claiming that a five to 10mm “ice ball” margin beyond the tumour is necessary for effective cryoablation. Three millimetre “ice ball” margin beyond renal tumours adequate for effective cryoablation

Philips expands interventional oncology portfolio with EmboGuide to see, reach and treat tumour lesions

Friday, 16 May 2014
New live 3D image guidance tool enhances tumour embolization procedures on Philips’ interventional X-ray systems. Philips expands interventional oncology portfolio with EmboGuide to see, reach and treat tumour lesions
Reducing the perils of ablation for thermally sensitive adjacent organs

Reducing the perils of ablation for thermally sensitive adjacent organs

Friday, 16 May 2014
Over the years, we have seen a rapid development of tools, tricks and techniques that enable ablation of tumours located in regions that are in close proximity to thermally sensitive organs or structures, writes Nishita Kothary (Stanford University, USA). Reducing the perils of ablation for thermally sensitive adjacent organs

Surefire system vs. end hole catheter clinical trial eliminates patient variables

Monday, 05 May 2014
Preliminary observations from the trial were presented at the Global Embolization Symposium and Technologies US (GEST US meeting, 1–4 May, San Francisco, USA) and show increased tumour penetration with the Surefire system. Surefire system vs. end hole catheter clinical trial eliminates patient variables
Interventional radiology techniques and results for the management of neuroendocrine liver metastases

Interventional radiology techniques and results for the management of neuroendocrine liver metastases

Wednesday, 30 Apr 2014
Interventional radiology techniques are widely performed and useful in liver metastases from neuroendocrine tumours, but the level of scientific proof is paradoxically low, especially when considering that these techniques are used in patients with cancer, write Maxime Ronot and Valérie Vilgrain Interventional radiology techniques and results for the management of neuroendocrine liver metastases
COSY trial shows highly reduced radioembolization procedure time and radiation dose

COSY trial shows highly reduced radioembolization procedure time and radiation dose

Friday, 28 Mar 2014
Surefire Medical has announced that the COSY clinical trial (Coiling vs. Surefire infusion system in Y90) showed significant reductions in fluoroscopy time, procedure time, radiation dose and contrast dose when using the Surefire Infusion System without coiling. COSY trial shows highly reduced radioembolization procedure time and radiation dose
Found: 154   Displaying: 1-20
Results: 1 2 3 4 5 Next Go to:

Related Section


Clinical Trials
Interventional Oncology News
Interventional Oncology Supplement
Key Opinion Leaders discuss the role of Biocompatible's DC Bead at CIRSE and ILCA
IR Views
Literature
Oncology Useful Links

Related Feeds


Most popular


Biolas introduces VariClose in Europe
Thursday, 16 Jul 2015
After the European launch in April 2015, Biolas has introduced the VariClose Vein Sealing Systems in the European market for the treatment of varicose veins. Biolas introduces VariClose in Europe

Cyanoacrylate embolisation agent non-inferior to radiofrequency ablation for incompetent great saphenous veins treatment
Friday, 03 Jul 2015
Twelve-month results from the VeClose trial have demonstrated cyanoacrylate adhesive (CAE) is non-inferior to radiofrequency ablation (RFA) for the treatment of incompetent great saphenous veins. Cyanoacrylate embolisation agent non-inferior to radiofrequency ablation for incompetent great saphenous veins treatment

Lombard Medical acquires EVAR stent graft developer Altura Medical
Friday, 31 Jul 2015
Altura Medical has developed an ultra-low profile endovascular stent graft technology that, according to Lombard, offers a simple and predictable solution for the treatment of standard abdominal ... Lombard Medical acquires EVAR stent graft developer Altura Medical

Features


Choosing horses for courses: Using liquid agents to embolize endoleaks
Monday, 27 Jul 2015
Robert Morgan, vascular interventional radiologist, St Georges Hospital, London, UK, tells Interventional News why he uses liquid embolic agents, such as ethylene vinyl oxide copolymer (EVOH-based) ... Choosing horses for courses: Using liquid agents to embolize endoleaks

Aneurysm Coiling Efficiency (ACE) registry shows positive results for Ruby coil peripheral vasculature
Wednesday, 10 Jun 2015
The Aneurysm Coiling Efficiency registry offers an opportunity to study the demographics and long-term outcomes of a cohort of patients with embolization of the peripheral vasculature using Ruby ... Aneurysm Coiling Efficiency (ACE) registry shows positive results for Ruby coil peripheral vasculature

Profiles


Lindsay Machan
Thursday, 28 May 2015
“Focussing on maximising rewards has sidelined more ideas than it has helped individual inventors. S... Lindsay Machan

Gao-Jun Teng
Thursday, 11 Dec 2014
In the future, will interventional radiology be a subspecialty of radiology, or surgery? asks Gao-J... Gao-Jun Teng

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions